Difficulty: Medium
Average Score: 75%
Practice
Mesalazine:
Correct answer
B
Rationale
In the context of drugs affecting gastrointestinal secretions, understanding Mesalazine is crucial for healthcare professionals. The correct answer is B) Dissolves at the pH found in the terminal ileum and colon. Mesalazine is designed to release 5-aminosalicylic acid in the colon, where it exerts its anti-inflammatory effects. This property is essential for targeting diseases like ulcerative colitis and Crohn's disease that affect the lower gastrointestinal tract.
Option A is incorrect because Mesalazine is the active form of the drug, not a prodrug consisting of a dimer of two 5-aminosalicylic acid molecules. Option C is incorrect as mesalazine is generally well-tolerated even in patients with sulphonamide hypersensitivity due to its different chemical structure. Option D is incorrect as oligospermia is not a known side effect of mesalazine therapy.
Educationally, this question highlights the importance of understanding the pharmacokinetics of drugs used in gastrointestinal disorders. Knowing how Mesalazine functions in the body helps healthcare providers make informed decisions when treating patients with inflammatory bowel diseases. This knowledge ensures safe and effective drug therapy for better patient outcomes.
Option A is incorrect because Mesalazine is the active form of the drug, not a prodrug consisting of a dimer of two 5-aminosalicylic acid molecules. Option C is incorrect as mesalazine is generally well-tolerated even in patients with sulphonamide hypersensitivity due to its different chemical structure. Option D is incorrect as oligospermia is not a known side effect of mesalazine therapy.
Educationally, this question highlights the importance of understanding the pharmacokinetics of drugs used in gastrointestinal disorders. Knowing how Mesalazine functions in the body helps healthcare providers make informed decisions when treating patients with inflammatory bowel diseases. This knowledge ensures safe and effective drug therapy for better patient outcomes.